US Blacklists Three Chinese Genomics Firms Over Xinjiang Allegations — What the Import Ban Means
· News Team
WASHINGTON, October 29, 2026 — U.S. authorities have added three Chinese genomics businesses to a forced-labor enforcement list, extending a trade restriction into the equipment and services used to analyze genetic material. The decision raises a practical question for American buyers: which shipments may be stopped, and what evidence would be needed to release them?
What changed
On October 28, the Department of Homeland Security announced the addition of BGI Genomics Co. Ltd., MGI Tech Co. Ltd. and Shenzhen BGI Technology Co. Ltd. — also identified by U.S. authorities as BGI Group — to the Uyghur Forced Labor Prevention Act (UFLPA) Entity List. The Associated Press reported that U.S. Customs and Border Protection would begin applying the new restrictions on Thursday, October 29. The additions bring the reported number of listed entities to 190.
The listing does not mean that every genetic test or every piece of sequencing equipment sold worldwide is prohibited. Under the UFLPA, goods produced wholly or partly by a listed entity are subject to a rebuttable presumption that forced labor was involved. Such goods are generally barred from U.S. entry unless the importer satisfies the statutory standard to overcome that presumption. This is an import-enforcement measure, not a finding that individual patients or laboratories have committed wrongdoing.
What Washington alleges — and what the companies dispute
According to the U.S. government, the companies have been involved in genetic testing connected to authorities in China’s Xinjiang region. DHS alleges that the testing and related equipment supported surveillance and coercive labor practices affecting Uyghurs and other minority groups. These are government allegations, not findings established independently by Tectonics Media Publications.
BGI Group and MGI Tech rejected the accusations. Reuters reported that both companies said they opposed forced labor, while BGI Group described its U.S. business as a small part of its operations. China’s embassy in Washington also rejected the U.S. claims. BGI Genomics had not immediately responded to Reuters’ request for comment at the time of its report.
Why laboratories and suppliers should pay attention
The immediate issue for importers is supply-chain traceability. A U.S. distributor may need to determine not only which company sells a finished instrument, but also whether any covered entity produced all or part of the goods. That creates potential delays and documentation costs even when an importer believes its products are compliant. The exact commercial impact is not yet measurable from the announcement alone.
There is also a broader policy tension. Genetic sequencing can support medical diagnostics, infectious-disease surveillance and research; genetic information can also create privacy and human-rights risks when collected without meaningful safeguards. The import listing addresses alleged labor-related conduct. It should not be confused with a general ban on DNA research or with proof that a particular U.S. laboratory has misused genetic data.
What happens next
U.S. importers will need to check the current official entity list, assess affected suppliers and review the documentation needed for shipments. The companies can seek removal through the federal listing process. Whether the action significantly changes the availability or price of sequencing equipment will depend on actual exposure to the listed entities and enforcement outcomes; neither can be quantified responsibly yet.
Reporting cutoff: October 29, 2026, approximately 01:00 UTC. This article will be updated if the official listing, company responses or implementation details change.
Sources and further reading
- Associated Press, October 28: U.S. import restrictions and company response.
- Reuters, October 28: DHS allegations, companies’ denials and import implications.
- U.S. Department of Homeland Security: UFLPA Entity List (official list; access may vary).
- U.S. Customs and Border Protection: explanation of UFLPA enforcement.
Image: Illustrative automated laboratory process, not a BGI or MGI facility. Photo by Testalize.me / Unsplash, used under the Unsplash License. No actual event footage is depicted. No verified authorized exact-event video was available at publication.
About The Author
